MANAGEMENT OF ADULT ACUTE LYMPHOBLASTIC LEUKEMIA WITH A PEDIATRIC-BASED REGIMEN: A SINGLE CENTER EXPERIENCE

EHA Library, Panayotis Kaloyannidis, 216189

ACUTE MYELOID LEUKAEMIA (AML) PATIENTS WITH CO-EXISTING T(8;21) AND TRISOMY 4 ABNORMALITIES

EHA Library, Lai Ching Lau, 216190

THE ROLE OF NA/H EXCHANGE I AS A THERAPEUTIC TARGET TO OVERCOME CYTARABINE RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, June-Won CHEONG, 216191

ANTI-LEUKEMIC EFFECTS OF VOSAROXIN, AN ANTI-CANCER QUINOLONE DERIVATIVE, ON HYPOMETHYLATING AGENT-RESISTANT CELLS

EHA Library, Han-Seung PARK, 216192

APPLICATION OF THE GENEREADER NGS SYSTEM AND QIAACT MYELOID DNA UMI PANEL IN DETECTING RELEVANT MUTATIONS FOR MYELOID LEUKEMIA RESEARCH, INCLUDING FLT3 ITDS

EHA Library, Veronique Laloux, 216193

CD44-HYALURONAN INTERACTION INDUCES VLA-4 CLUSTER FORMATION LEADING TO ENHANCED ADHESION OF AML CELLS ON VCAM-1.

EHA Library, Julia Gutjahr, 216194

ASYNCHRONOUS MONOCYTIC MATURATION PATTERN IN AML WITH NPM1 MUTATION

EHA Library, Miguel Ángel Álvarez Juárez, 216195

BONE MARROW LYMPHOCYTE PROFILE OF HLA-DR NEGATIVE NON-M3 ACUTE MYELOID LEUKEMIA

EHA Library, Silvia cingelova, 216196

EARLY REDUCTION OF WT1 TRANSCRIPT LEVEL DURING INDUCTION CHEMOTHERAPY PREDICTS FOR LONGER RELAPSE-FREE AND OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA

EHA Library, Larisa Girshova, 216197

FREQUENCY OF GENE MUTATIONS IN A COHORT OF COLOMBIAN PATIENTS WITH ACUTE MYELOID LEUKEMIA BEFORE AND AFTER INDUCTION TREATMENT

EHA Library, Jeanette Prada-Arismendy, 216198

LNCRNA BALR-2-CDK6 AXIS INFLUENCES METABOLIC STATUS AND CELL DIFFERENTIATION OF ACUTE MYELOID LEUKEMIA.

EHA Library, Valeria Bisio, 216199

IDENTIFICATION OF A LONG NON-CODING RNA (LNCRNA) ASSOCIATED WITH FAVORABLE OUTCOME IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Anne Neddermeyer, 216200

A QUARTER OF NRAS POSITIVE PATIENTS CARRY MULTIPLE POINT MUTATIONS, EACH OF THEM LOCALISED SEPARATELY IN DIFFERENT ALLELES

EHA Library, Anna Durinikova, 216201

BONE MARROW PLASMA LEVELS OF S100A8 ARE SIGNIFICANTLY INCREASED IN SOME SUBGROUPS OF AML PATIENTS WITH BETTER PROGNOSTIC

EHA Library, Julie Mondet, 216202

RELATIONSHIP AMONG EXPRESSION LEVELS OF EPIGENETIC MODULATORS IN AML OF INTERMEDIATE RISK: BIOLOGICAL ASSOCIATIONS AND OUTCOME INFLUENCE

EHA Library, Cristina Bilbao, 216203

ROLE OF CLEC12A IN THE LSC COMPARTMENT OF PEDIATRIC ACUTE MYELOID LEUKEMIA AT DIAGNOSIS VERSUS RELAPSE

EHA Library, Barbara Depreter, 216204

SENSITIVE AND EARLY DETECTION OF THE PML-A216V MUTATION BY DROPLET DIGITAL PCR IN ARSENIC TRIOXIDE RESISTANT ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Valentina Alfonso, 216205

A NGS-BASED APPROACH FOR MOLECULAR CLASSIFICATION OF ACUTE MYELOID LEUKEMIA (AML) WITH INTERMEDIATE-PROGNOSTIC CYTOGENETIC RISK

EHA Library, Eleonora Toffoletti, 216206

GENOMIC-DRIVEN TRANSLATIONAL AND METABOLIC PERTURBATIONS IN ACUTE MYELOID LEUKEMIA CELLS UNDER THE SELECTIVE PRESSURE OF BROMODOMAIN INHIBITION IN THE HYPOXIC MICROENVIRONMENT

EHA Library, Giorgia Simonetti, 216207

DESCRIPTION OF ACUTE MYELOBLASTIC LEUKEMIA WITH ISOLATED TRISOMY 13. EXPERIENCE OF FIVE CENTERS.

EHA Library, David Cruz, 216208

MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA WITH NORMAL CYTOGENETICS IN ROMANIAN PATIENTS – A TARGETED NEXT GENERATION SEQUENCING PRELIMINARY REPORT

EHA Library, Aurora Arghir, 216210

HISTONE DEACETYLASE 1 INDUCED BY NEDDYLATION INHIBITION CONTRIBUTES TO DRUG RESISTANCE IN ACUTE MYELOGENOUS LEUKEMIA

EHA Library, Liang Wang, 216211

DETECTION OF FLT3-INTERNAL TANDEM DUPLICATION WITH NGS: A COMPARISON OF DIFFERENT ANALYTICAL TOOLS.

EHA Library, Marie Le Mercier, 216212

GENE EXPRESSION PROFILING REVEALS A THREE-GENE ANTIAPOPTOTIC SIGNATURE USEFUL TO SWITCH-OFF ANTIAPOPTOTIC STIMULI IN ACUTE MYELOID LEUKEMIA

EHA Library, Jacopo Nanni, 216213

HAEMATOLOGICAL CANCERS & THE 100,000 GENOMES PROJECT - CREATING CLINICAL PATHWAYS TO ENABLE WHOLE GENOME SEQUENCING IN A DIAGNOSTIC SETTING.

EHA Library, Shirley Henderson, 216214

JQ1 TREATMENT OF U937 CELL LINES OF STAT - 5 SIGNAL TRANSDUCTION PATHWAYS RESEARCH

EHA Library, Ma Liangming, 216215

THE EFFECT OF THE CRM1 INHIBITING COMPOUND KPT-330 ON P53 ISOFORM PROFILE

EHA Library, Ehsan Hajjar, 216216

HIGH-THROUGHPUT DRUG SCREENING TO IDENTIFY THERAPIES REVERSING ABERRANT CELL DIFFERENTIATION IN AML.

EHA Library, Ella Karjalainen, 216217

IN VITRO AND IN VIVO MODELS OF ACUTE MYELOID LEUKEMIA USING CRISPR/CAS9 SYSTEM

EHA Library, Elisa Gonzalez, 216218

THE DNA DAMAGE REPAIR PATHWAY IS ALTERED IN POOR PROGNOSIS ACUTE MYELOID LEUKEMIA PATIENTS AND IDENTIFIES POTENTIAL TARGETS FOR SYNTHETIC LETHAL THERAPIES

EHA Library, Antonella Padella, 216219

THE ROLE OF DNA REPAIR MECHANISMS IN ACUTE MYELOID LEUKAEMIA

EHA Library, Clare Crean, 216220

BRIVANIB ALANINATE KILLS LEUKEMIC STEM CELL BY INHIBITING VASCULAR ENDOTHELIAL GROWTH FACTOR-2 AND FIBROBLAST GROWTH FACTOR RECEPTORS

EHA Library, Shayan Alikhani, 216221

ESTIMATING THE OPTIMAL THRESHOLD OF BAALC AND ERG AS PREDICTIVE BIOMARKERS IN ACUTE MYELOID LEUKEMIA

EHA Library, Syed Khizer Hasan, 216222

PRO-APOPTOTIC EFFECTS OF A METABOLIC-ORIENTED TREATMENT IN ACUTE MYELOID LEUKEMIA

EHA Library, Cristina Banella, 216223

FREQUENCY AND SIGNIFICANCE OF DICENTRIC CHROMOSOMES IN BONE MARROW CELLS OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Sarka Ransdorfova, 216224

PROGNOSTIC IMPACT OF DNMT3A MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) WITH NPM1MUTATION DEPENDING ON FLT3 MUTATIONAL STATUS

EHA Library, Guadalupe Oñate, 216225

PECULIARITIES OF IMMUNOLOGICAL INDICATORS IN ACUTE MYELOBLASTIC LEUKEMIA IN DYNAMICS

EHA Library, Olga Smirnova, 216226

DYNAMICS OF METABOLIC INDICATORS OF ACUTE NON-LYMPHOBLASTIC LEUKEMIA

EHA Library, Olga Smirnova, 216227

ANTI-CD CELL-BINDING ANTIBODY MICROARRAY FOR INTEGRATION OF MORPHOLOGY AND IMMUNOPHENOTYPING IN ACUTE LEUKEMIA DIAGNOSIS

EHA Library, Sofya Kuznetsova, 216228

SRSF2 GENE MUTATIONS ARE ASSOCIATED WITH TP53Γ EXPRESSION LEVELS AND OVERALL SURVIVAL IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML).

EHA Library, Karolina Matiakowska, 216229

INVESTIGATING THE EFFECT OF C-MYC PROTO-ONCOGENE INHIBITION IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Mohammad sayyadi, 216230

THE ROLE OF S100A4 IN ACUTE MYELOID LEUKEMIA

EHA Library, Bader Alanazi, 216231

EXPLORATORY BIOMARKER ANALYSIS IN AML PATIENTS TREATED WITH ORAL SYK INHIBITOR ENTOSPLETINIB (GS-9973)

EHA Library, Veerendra Munugalavadla, 216232

INHIBITION OF DNA METHYLTRANSFERASES BY VOLASERTIB IN HMA RESISTANT CELL LINES

EHA Library, Sun-Hye Ko, 216233

TO IDENTIFY PROGNOSTIC BIOMARKER AND GENE REGULATION BY TCGA DATASET: ALDH1A1 IN ACUTE MYELOID LEUKEMIA

EHA Library, Hai Yi, 216234

THE PROLIFERATION INDEX OF BONE MARROW CELLS FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC MYELOMONOCYTIC LEUKEMIA VS. ACUTE MONOBLASTIC/MONOCYTIC LEUKEMIAS

EHA Library, Pilar Leoz Allegretti, 216235

MDR1 GENE DETECTED IN VITRO HAVE A PROGNOSTIC SIGNIFICANCE IN LEUKEMIA PATIENTS

EHA Library, Maria Kolesnikova, 216236

KARYOTYPE COMPLEXITY AND CHARACTERIZATION OF CHILDHOOD ACUTE MYELOID LEUKEMIA (AML) IN PAKISTAN

EHA Library, Zeeshan Ahmed, 216237

SYNERGISTIC EFFECTS OF PI3K AND C-MYC CO-TARGETING IN ACUTE MYELOID LEUKEMIA: PROPOSING NOVEL THERAPEUTIC POTENTIAL FOR AML

EHA Library, niknam riyahi, 216238

JAGGED-1 EXPRESSION IN MESENCHYMAL STROMAL CELLS HAS DISTINCT EFFECTS ON FLT3 MUTATED LEUKEMIA CELLS

EHA Library, Manja Wobus, 216239

PHARMACOLOGICAL INHIBITION OF WIP1 SENSITIZES ACUTE MYELOID LEUKEMIA CELLS TO MDM2 INHIBITORS

EHA Library, Maria Chiara Fontana, 216240

STRATEGIES OF AFFECTING CELLULAR LOCALIZATION TO OVERCOME RESISTANCE IN FLT3-ITD-POSITIVE AML CELLS

EHA Library, Ulf Schnetzke, 216241

MOLECULAR CHARACTERIZATION OF PEDIATRIC ACUTE MYELOID LEUKEMIA: RESULTS OF A PROSPECTIVE MULTICENTRIC STUDY IN RUSSIA

EHA Library, Agnesa Panfyorova, 216242

RISK FACTORS AND OUTCOMES OF PATIENTS WITH RELAPSED CORE-BINDING FACTOR-POSITIVE ACUTE MYELOID LEUKEMIA

EHA Library, Marijana Virijevic, 216243

OUTCOME OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA IN A SINGLE INSTITUTION

EHA Library, Ana García-Noblejas, 216244

REGISTRY FOR THE OFF-LABEL USE OF VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Rabia Shahswar, 216245

FEASIBILITY AND EFFICACY OF INTENSIVE SALVAGE TREATMENTS FOR ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA

EHA Library, Bernardi Massimo, 216246

IMPACT OF BONE MARROW ASPIRATE TREGS ON THE RESPONSE RATE OF YOUNGER NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Mario Delia, 216247

IMPORTANCE OF CLINICAL RISK IN CYTOGENETIC-MOLECULAR FAVOURABLE RISK AML WITH NPM MUTATED, FLT3-ITD UNMUTATED AND NORMAL KARYOTYPE.

EHA Library, Maria Vittoria Dubbini, 216248

RARE REPORT OF PROMYELOCYTIC SARCOMA AFTER RENAL TRANSPLANT

EHA Library, Li-Jing Shen, 216249

INTENSIVE INDUCTION TREATMENT OF ACUTE MYELOID LEUKEMIA IN PATIENTS AGED ABOVE 60 IN SHATHD BETWEEN 1.01.2010 AND 1.01.2018, PROGNOSTIC FACTORS FOR INDUCTION MORTALITY

EHA Library, Stefan Lozenov, 216250

OUTPATIENT-BASED HIGH DOSE CYTARABINE FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA: SAFE, FEASIBLE AND COST EFFECTIVE APPROACH

EHA Library, Panayotis Kaloyannidis, 216251

REAL LIFE SINGLE CENTER EXPERIENCE WITH TREATMENT REGIMENS IN ADULT PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA – EARLY DEATH RATES (2002-2018)

EHA Library, Iveta Oravcova, 216252

EARLY MORTALITY IN ACUTE MYELOID LEUKEMIA WITH HYPERLEUKOCYTOSIS

EHA Library, Andreea Moicean, 216253

PHARMACOKINETICS OF HU5F9-G4 A FIRST IN CLASS ANTI-CD47 ANTIBODY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Balaji Agoram, 216254

DOES THE ICU ADMISSION OF THE DE NOVO AML PATIENTS DURING REMISSION INDUCTION HAVE INFLUENCE ON THE LONG-TERM OUTCOME?

EHA Library, Aleksei Bazhenov, 216255

AZACITIDINE OR DECITABINE FRONTLINE THERAPY FOR ACUTE MYELOID LEUKEMIA IN ELDERLY PATIENTS?

EHA Library, Silvia Imbergamo, 216256

AN EFFECTIVE TOOL FOR COMPREHENSIVE GERIATRIC ASSESSMENT IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Chun-Li Zhang, 216257

IMPACT OF DIFFERENT BY INTENSITY CONSOLIDATION REGIMENS ON MINIMAL RESIDUAL DISEASE REDUCTION AND RELAPSE INCIDENCE IN ADULTS WITH ACUTE MYELOID LEUKEMIA.

EHA Library, Tatiana Lobanova, 216258

CORRELATION OF INTERLEUKIN-6, INTERLEUKIN-10, AND TRANSFORMING GROWTH FACTOR BETA SERUM LEVELS WITH THE RESPONSE TO INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Tareq Salah, 216259

REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA PATIENTS WITH HIGH CD117 EXPRESSION BUT WITHOUT FLT3-ITD MUTATION COULD BE A SPECIAL GROUP WITH GOOD RESPONSES TO SORAFENIB TREATMENT ALONE

EHA Library, Jianhui Xu, 216260

DETECTION OF PML-RARA IN APL: COMPARING FISH, PCR AND CONVENTIONAL KARYOTYPING

EHA Library, Marta Pereira, 216261

BRAF MUTATION IN BOTH HAIRY CELL LEUKEMIA AND PAPILLARY THYROID CANCER IN THE SAME PATIENT.

EHA Library, Shehab Fareed Abdelgabber, 216262

DEFINING A TECHNICAL WORKFLOW FOR GENE EXPRESSION PROFILING IN MRD+ CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Alba Mora, 216263

DRUG SENSITIVITY SCREENING IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) FOR PRECISION CANCER THERAPY.

EHA Library, Deepak balaji Thimiri Govinda Raj, 216264

EXPRESSION OF THE APOPTOSIS-RELEATED GENES IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA IN CLINICAL DATA CONTEXT

EHA Library, Sergey Zakharov, 216265

TARGETING THE INTERPLAY BETWEEN HSP70 (HEAT SHOCK PROTEIN OF 70KDA) AND HSF1 (HEAT SHOCK FACTOR 1) IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Flavia Raggi, 216266

A METHYL-CPG BINDING DOMAIN SEQUENCING STUDY SHOWED DYSREGULATED METHYLATION IN GENES INVOLVED IN CANCER, IMMUNITY, LYMPHOID DIFFERENTIATION AND MAJOR SIGNALING PATHWAYS IN ASIAN CLL

EHA Library, Eunyup Lee, 216267

THE IMPORTANCE OF MOLECULAR AND CYTOGENETIC ABERRATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Elena Nazarova, 216268

MUTATIONAL STATUS, IGHV GENE REARRANGEMENTS AND STEREOTYPED RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS FROM A SOUTH AMERICAN MULTICENTER STUDY

EHA Library, Carmen Stanganelli, 216269

THE POSSIBLE ROLE OF TLR2 AND TLR9 RECEPTOR DYSFUNCTION IN THE PATHOGENESIS AND PROGRESSION OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Agnieszka Szymczyk, 216270

CHARACTERIZATION OF IGHVDJ REARRANGEMENTS AND CHROMOSOMAL ALTERATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Miguel Ángel Perera Álvarez, 216271

QUADRANT ANALYSIS OF DRUG APPROVAL AND EMERGING TREATMENT TRENDS IN CHRONIC LYMPHOCYTIC LEUKEMIA – A RETROSPECTIVE STUDY ON PIVOTAL CLINICAL TRIALS

EHA Library, Maneesha Chhikara, 216272

MONOCLONAL GAMMOPATHY AND HYPOGAMMAGLOBULINEMIA AS INDEPENDENT PROGNOSTIC FACTORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A RETROSPECTIVE MONOCENTRIC EXPERIENCE.

EHA Library, Luca Laurenti, 216273

MONOCLONAL B-CELL LYMPHOCYTOSIS IN GREEK POPULATION

EHA Library, Eleftheria Ztriva, 216274

THE EXPRESSION LEVEL OF CD 177 IS INCREASED IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISEASES AND MYELOID NEOPLASIAS

EHA Library, Irina Krobinets, 216275

UNCLASSIFIABLE ISOLATED MONOCLONAL HYPERLYMPHOCYTOSIS: COMPREHENSIVE DESCRIPTION OF A RETROSPECTIVE COHORT

EHA Library, Michaël Degaud, 216276

IMMUNOLOGICAL RECONSTITUTION AND PLATELET DISFUNCTION DURING IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Idanna Innocenti, 216277

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING TREATMENT WITH IBRUTHINIB.

EHA Library, Gennady Gendlin, 216278

SAFETY AND EFFICACY OF BENDAMUSTINE AND RITUXIMAB COMBINATION CHEMOTHERAPY AS FIRST LINE TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE CENTRE EXPERIENCE FROM NORTH INDIA

EHA Library, Anil Tripathi, 216279

ANALYSIS OF PERCENT IDENTITY OF IGHV MUTATION AS PROGNOSTIC FACTOR IN CLL PATIENTS TREATED WITH FLUDARABINE, CYCLOFOSFAMIDE AND RITUXIMAB: A SINGLE CENTRE EXPERIENCE

EHA Library, Annamaria giordano, 216280

ADVANCED DATA-MINING METHODS REVEALED FOUR SUBGROUPS AMONG HIGH-RISK CLL PATIENTS

EHA Library, Peter Turcsanyi, 216281

HIGH DOSE METHYLPREDNISOLONE AND RITUXIMAB IN RELAPSED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Regina Pileckyte, 216282

MULTICENTRIC REAL LIFE COHORT OF UNSELECTED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL): MOLECULAR ANALYSIS, CLINICAL INTEGRATION AND PROGNOSTIC IMPLICATIONS.

EHA Library, Roberta MURRU, 216283

IBRUTINIB IN THE TREATMENT OF EARLY RELAPSE OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Natalia Timofeeva, 216284

DOES THE DOSE MODIFICATION OF FLUDARABINE, CYCLOPHOSPHAMIDE, RITUXIMAB (FCR) IMPACT TREATMENT OUTCOME IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA? ANSWER BASED ON SINGLE CENTER „REAL-LIFE“ DATA

EHA Library, Vojin Vukovic, 216285

ASSOCIATION OF INITIAL PROGNOSTIC PARAMETERS AND REQUIREMENT FOR TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Aysun SENTURK YIKILMAZ, 216286

DISCORDANCE IN THE THRESHOLDS OF EARLY RELAPSE IN CLL GUIDELINES

EHA Library, Vladimir Strugov, 216287

INFLUENCE OF INTENSITY CHEMOTHERAPY ON THE FREQUENCY OF MRD NEGATIVE REMISSIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Maria Mikhaleva, 216288

SAFETY PROFILE OF IBRUTINIB: A RETROSPECTIVE ANALYSIS OF 31 PATIENTS

EHA Library, Jasone Uriarte Elguezabal, 216289